CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

HDFC Pharma and Healthcare Fund-Reg(G)

very highequitypharma & health care
17.45 0.02(0.13%) NAV as on 12 Feb 2026
1.67 % 1 M
12.43 % 1 Y
NA 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.10

As on 31 Dec, 2025
age-icon Age :

2 yrs 4 m

Since 04 10 ,2023
exit_load Exit Load :

1%

aum AUM :

1,875.89 Crs

lock_in Lock-in :

1% on or before 30D, Nil after 30D

investing_style Investing Style :

Mid Growth

Portfolio_book_value Portfolio Price To Book Value :

7.47

Min_Investment Min. Investment :

SIP 100 & Lumpsum 100

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Nikhil Mathur

LATEST ASSET & PORTFOLIO ALLOCATION

as on Jan 31 ,2026
Others 2.67 %
Equity 97.33 %

TOP HOLDINGS

Sun Pharmaceutical Industries...9.75 %
Divi's Laboratories Ltd.8.57 %
Glenmark Pharmaceuticals Ltd.6.76 %
Lupin Ltd.6.52 %
Alkem Laboratories Ltd.6.42 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs69.68
Hospital & Healthcare Services25.84
Miscellaneous1.16
Medical Equipment/Supplies/Accessories0.65
See All Sectors

5-YEARS HISTORY

Financial Year2023-20242024-20252025-2026
NAV in Rs (as on 12-Feb-2026)12.2915.9217.45
Net Assets(Rs Crores) (as on 12-Feb-2026) 800.65 1634.08 1875.89
Scheme Returns(%)(Absolute)23.3028.3511.52
B'mark Returns(%)(Absolute)NANANA
Category Rank66/901/10243/115

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

HDFC Pharma and Healthcare Fund-Reg(G)Very HighEquity17.450.02(0.13%)NAV As on 12 Feb, 202604-Oct-2023Inception Date1,875.89AUM In Cr.12.43%1YNA%3YNA%5Y26.79%Since Inception
UTI Healthcare Fund-Reg(G)Very HighEquity283.41-0.37(-0.13%)NAV As on 12 Feb, 202601-Aug-2005Inception Date1,055.01AUM In Cr.7.76%1Y24.30%3Y14.92%5Y17.68%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity421.77-1.37(-0.32%)NAV As on 12 Feb, 202614-Jul-1999Inception Date3,822.73AUM In Cr.4.49%1Y24.12%3Y15.85%5Y15.82%Since Inception
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity30.71-0.08(-0.26%)NAV As on 12 Feb, 202610-Jul-2019Inception Date812.03AUM In Cr.7.45%1Y22.04%3Y13.47%5Y18.53%Since Inception
corporate OFFICE Jhaveri Securities301/302 Payal Tower-II,Opp. M. S. University, Sayajigunj, Vadodara 390020.
CALL US 91-265-6161200/7161200
EMAIL US info@jhaveritrade.com
SEBI Reg. No. NSE, BSE, MCX : INZ000199232 Membership No.: NSE:08232, BSE:3015, MCX:56465 SEBI Regn.No. of DP : IN-DP-195-2016 (NSDL DPID:IN301991) AMFI: ARN-A3524 CIN of JSL: U67120GJ1992PLC018194 | GST : 24AAACJ4727A2Z4
COMPLIANCE OFFICER OFFICE
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors
© CopyRights 2022, Jhaveri Securities All rights reserved.
Designed & Developed by Accord Fintech Pvt Ltd.